U S GLOBAL INVESTORS INC

NOTE1. BASIS OF PRESENTATION AND CONSOLIDATION

U.S. Global Investors, Inc. (the “Company” or “U.S. Global”) has prepared the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the rules and regulations of the United States Securities and Exchange Commission (“SEC”) that permit reduced disclosure for interim periods. The financial information included herein reflects all adjustments (consisting solely of normal recurring adjustments), which are, in management’s opinion, necessary for a fair presentation of results for the interim periods presented. The Company has consistently followed the accounting policies set forth in the notes to the Consolidated Financial Statements in the Company’s Form10-K for the fiscal year ended* June 30, 2025* ("Form10-K").

The Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries, U.S. Global Investors (Bermuda) Limited, U.S. Global Investors (Canada) Limited (“USCAN”), and U.S. Global Indices, LLC.

There aretwo primary consolidation models in U.S. GAAP, the variable interest entity (“VIE”) and voting interest entity models. The Company’s evaluation for consolidation includes whether entities in which it has an interest or from which it receives fees are VIEs and whether the Company is the primary beneficiary of any VIEs identified in its analysis. A VIE is an entity in which either (a) the equity investment at risk isnot sufficient to permit the entity to finance its own activities without additional financial support or (b) the group of holders of the equity investment at risk lack certain characteristics of a controlling financial interest. The primary beneficiary is the entity that has the obligation to absorb a majority of the expected losses or the right to receive the majority of the residual returns and consolidates the VIE on the basis of having a controlling financial interest.

The Company has variable interests in certain funds it advises, specifically, certain funds within U.S. Global Investors Funds (“USGIF” or the “Funds”) and certain U.S Global exchange-traded fund ("ETF") clients. However, isnot deemed to be the primary beneficiary of these funds. The Company’s interests in these VIEs consist of the Company’s direct ownership therein and any fees earned but uncollected. See further information about these funds in Notes2 and3. In the ordinary course of business, the Company* maychoose to waive certain fees or assume operating expenses of the funds it advises for competitive, regulatory or contractual reasons (see Note3* for information regarding fee waivers). The Company hasnot provided financial support to any of these entities outside the ordinary course of business. The Company’s risk of loss with respect to these VIEs is limited to the carrying value of its investments in, and fees receivable from, the entities. The Company isnot deemed to be the primary beneficiary because it doesnot have the obligation to absorb a majority of the expected losses or the right to receive the majority of the residual returns. The Company doesnot consolidate these VIEs because it isnot the primary beneficiary. The Company’s total exposure to unconsolidated VIEs, consisting of the Company's investments in these entities (as reflected in the carrying value of investments in securities) and receivables for fees, was $10.4 million at* March 31, 2026*, and $11.0 million at* June 30, 2025*.

The carrying amount of assets and liabilities recognized in the Consolidated Balance Sheets related to the Company's interests in these non-consolidated VIEs were as follows:

Since the Company isnot the primary beneficiary of the above funds it advises, the Company evaluated if it should consolidate under the voting interest entity model. Under the voting interest model, for legal entities other than partnerships, the usual condition for control is ownership, directly or indirectly, of more than50 percent of the outstanding voting shares over an entity. The Company doesnot have control of any of the above funds it advises; therefore, the Company doesnot consolidate any of these funds.

All significant intercompany balances and transactions have been eliminated in consolidation. Certain amounts have been reclassified for comparative purposes. Due to rounding, the year-to-date amount* may**not* be the exact sum of the quarterly amounts. The results of operations for the interim periods disclosed herein arenot necessarily indicative of the results the Company* mayexpect for the fiscal year ending June 30,*2026 (“fiscal2026”).

The unaudited interim financial information in these Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements contained in the Company’s annual report on Form10-K; interim disclosures generally donot repeat those in the annual statements.

Use of Estimates

Preparation of the Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Consolidated Financial Statements and accompanying notes. Actual results* may*materially differ from those estimates.

Recent Accounting Pronouncements

In* June 2022,the FASB issued ASU2022*-03, Fair Value Measurement (Topic820*): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions* (“ASU2022-03”) to clarify the guidance in Topic820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The standard became effective for the Company on* July 1, 2024.The adoption of the standard didnot* have a material impact on the Company's Consolidated Financial Statements.

In* November 2023,the FASB issued Accounting Standards UpdateNo.* 2023-07, Segment Reporting (Topic280*): Improvements to Reportable Segment Disclosures* (“ASU2023-07”), which enhances annual and interim disclosure requirements for reportable segments. The amendments require additional, more detailed disclosures about significant segment expenses and other segment items. The Company adopted ASU2023-07 retrospectively for its fiscal year2025 annual Consolidated Financial Statements. While the adoption of ASU2023-07 didnot have a material impact on the Company’s Consolidated Financial Statements, it resulted in enhanced segment disclosures.

Page7

In* December 2023,the FASB issued ASU2023*-09, Income Taxes (Topic740*): Improvements to Income Tax Disclosures* (“ASU2023-09”), which enhances the transparency and decision usefulness of annual income tax disclosures. ASU2023-09 will be effective for fiscal years beginning after* December 15, 2024,and will be effective for the Company's fiscal2026* annual disclosures. Early adoption is permitted for annual financial statements that havenot yet been issued or made available for issuance. The Company expects the adoption of ASU2023-09 to result in enhanced income tax disclosures, including expanded rate reconciliation detail and disaggregated information regarding income taxes paid, in its annual consolidated financial statements. The adoption isnot expected to have a material impact on the Company's consolidated financial position, results of operations or cash flows.

In* November 2024,the FASB issued ASU2024*-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic220*-40): Disaggregation of Income Statement Expenses* (“ASU2024-03”), which requires public business entities to disclose specified information about certain costs and expenses. ASU2024-03 will be effective for annual reporting periods beginning after* December 15, 2026,and interim reporting periods with annual reporting periods beginning after December 15, 2027.Early adoption is permitted. The Company is currently evaluating the impact of ASU2024*-03 on its Consolidated Financial Statement disclosures.

In* December 2025,the FASB issued ASU2025*-11,* Interim Reporting (Topic270): Narrow-Scope Improvements (“ASU2025-11”), which clarifies the applicability, form and content, and required disclosures of interim financial statements. The amendments arenot* intended to change the fundamental nature of interim reporting, but instead improve the clarity and navigability of the existing guidance. The amendments create a comprehensive list of required interim disclosures and introduce a disclosure principle requiring entities to disclose, in interim periods, any event or change since the previous year-end that has a material effect on the entity. ASU2025-11 will be effective for interim reporting periods within annual reporting periods beginning after* December 15, 2027.Early adoption is permitted. The Company is currently evaluating the impact of ASU2025*-11 on its interim reporting disclosures.

NOTE2. INVESTMENTS

As of* March 31, 2026*, the Company held investments carried at fair value on a recurring basis of $12.4 million and a cost basis of $13.2 million. The fair value of these investments is approximately 25.4 percent of the Company’s total assets at* March 31, 2026*. In addition, the Company held other investments of approximately $4.7 million, and held-to-maturity debt investments, net of allowance for credit losses, of $961,000.

The cost basis of investments is adjusted for amortization of premium or accretion of discount on debt securities held and the recharacterization of distributions from investments in partnerships, if applicable.

Concentrations of Credit Risk

A significant portion of the Company’s investments carried at fair value on a recurring basis included investments in USGIF valued at $10.0 million as of* March 31, 2026*, and $10.5 million at* June 30, 2025*.

Fair Value Hierarchy

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The valuation techniques described below maximize the use of observable inputs and minimize the use of unobservable inputs in determining fair value.

The inputs used for measuring financial instruments at fair value are summarized in thethree broad levels listed below:

Level1 – Inputs represent unadjusted quoted prices for identical assets exchanged in active markets.

Level2 – Inputs include directly or indirectly observable inputs (other than Level1 inputs) such as quoted prices for similar assets exchanged in active or inactive markets; quoted prices for identical assets exchanged in inactive markets; other inputs that* may*be considered in fair value determinations of the assets, such as interest rates and yield curves; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Level3 – Inputs include unobservable inputs used in the measurement of assets. The Company is required to use its own assumptions regarding unobservable inputs because there is little, if any, market activity in the assets and it* may*be unable to corroborate the related observable inputs. Unobservable inputs require management to make certain projections and assumptions about the information that would be used by market participants in valuing assets.

The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. The inputs or methodology used for valuing securities arenot necessarily an indication of the risk associated with investing in those securities. Because of the inherent uncertainties of valuation, the values reflected* may*materially differ from the values received upon actual sale of those investments.

The Company has established a Proprietary Valuation Committee (the “Committee”) to administer and oversee the Company’s valuation policies and procedures, which are approved by the Board of Directors, and to perform a periodic review of valuations provided by independent pricing services.

For actively traded securities, the Company values investments using the closing price of the securities on the exchange or market on which the securities principally trade. If the security isnot traded on the last business day of the quarter, it is generally valued at the mean between the last bid and ask quotation. The fair value of a security that has a restriction greater thanone year is based on the quoted price for an otherwise identical unrestricted instrument that trades in a public market, adjusted for the estimated effect of the restriction. Contractual restrictions on the sale of an equity security arenot considered in measuring the security's fair value. Mutual funds, which include open- and closed-end funds and exchange-traded funds, are valued at net asset value or closing price, as applicable.

For common share purchase warrantsnot traded on an exchange, the estimated fair value is determined using the Black-Scholes option-pricing model. This sophisticated model utilizes a number of assumptions in arriving at its results, including the estimated life, the risk-free interest rate, and historical volatility of the underlying common stock. The Company* maychange the assumption of the risk-free interest rate and utilize the yield curve for instruments with similar characteristics, such as credit ratings and jurisdiction, or change the expected volatility. The effects of changing any of the assumptions or factors employed by the Black-Scholes model may*result in a significantly different valuation.

Page8

Certain convertible debt securitiesnot traded on an exchange are valued by an independentthird party. Thethird party* mayuse a binomial lattice model based on factors such as yield, quality, maturity, coupon rate, type of issuance, individual trading characteristics of the underlying common shares and other market data. A binomial lattice model utilizes a number of assumptions in arriving at its results. The effects of changing any of the assumptions or factors utilized in a binomial lattice model, including expected volatility, credit adjusted discount rates, and discounts for lack of marketability, may*result in a significantly different valuation for the securities.

For other securities included in the fair value hierarchy with unobservable inputs, the Committee considers a number of factors in determining a security’s fair value, including the security’s trading volume, market values of similar class issuances, investment personnel’s judgment regarding the market experience of the issuer, financial status of the issuer, the issuer’s management, and back testing, as appropriate. The fair values* maydiffer from what mayhave been used had a broader market for these securities existed. The Committee reviews inputs and assumptions and reports material items to the Board of Directors. Securities which donot* have readily determinable fair values are also periodically reviewed by the Committee.

The following tables summarize the major categories of investments with fair values adjusted on a recurring basis as of* March 31, 2026*, and* June 30, 2025*, and other investments with fair values adjusted on a nonrecurring basis, with fair values shown according to the fair value hierarchy.

Page9

The Company holds 15,000 common shares of HIVE, a company headquartered in the United States with cryptocurrency mining facilities in Paraguay, Sweden, and Canada, at a cost of $41,000. The investment had a fair value of $29,000 and $27,000 as of* March 31, 2026*, and* June 30, 2025*, respectively, and was classified within Level1 in the preceding tables. The common shares represent ownership in HIVE of less than 0.1 percent as of* March 31, 2026*. Frank Holmes serves on the board as executive chairman of HIVE and held options and restricted stock units at* March 31, 2026*. From* August 2018through January 2023,*Mr. Holmes was Interim CEO of HIVE.

The available-for-sale security carried at fair value on a recurring basis in the preceding table as of* June 30, 2025*, consisted of an investment in convertible debentures of HIVE. The Company purchased the convertible securities for $15.0 million in* January 2021.The investment comprised 8.0% interest-bearing unsecured convertible debentures, payable in quarterly installments with afive*-year term, and 5.0 million common share purchase warrants of HIVE. Under the original terms, the principal amount of each debenture was convertible into common shares of HIVE at a conversion price of $2.34 per share, and each warrant, which expired in* January 2024,entitled the Company to purchaseone* common share at an exercise price of $3.00 (Canadian). Following a reverse stock split, the conversion price of the debentures was adjusted to $11.70 per share. At* June 30, 2025*, the convertible securities didnot represent an ownership interest in HIVE. The securities were subject to Canadian securities regulations.

Upon acquisition, the Company recorded the convertible debentures at an estimated fair value of $16.0 million. An unrealized gain of $6.9 million was initially recognized in other comprehensive income (loss) and was subsequently realized in net investment income (loss) over time using the effective interest method.

At* June 30, 2025,the Company utilized an independentthird*-party valuation specialist to estimate the fair value of the HIVE convertible debentures. The Company determined that the fair value measurements utilized significant unobservable inputs and were therefore classified within Level3 of the fair value hierarchy. The fair value of the convertible debentures was $1.6 million at* June 30, 2025*. In* December 2025,the remaining principal amount of the convertible debentures was paid in full. The following table presents a reconciliation of investments measured at fair value using Level3* inputs.

Changes in Level3 Assets Measured at Fair Value on a Recurring Basis

The following is quantitative information with respect to the securities measured and carried at fair value on a recurring basis with the use of significant unobservable inputs (Level3) as of* June 30, 2025*.

Page10

Investments in Trading Securities at Fair Value

Investments in trading securities with readily determinable fair values are carried at fair value, and changes in unrealized gains or losses are reported within net investment income (loss). The following details the components of the Company’s trading securities carried at fair value as of* March 31, 2026*, and* June 30, 2025*.

Debt Investments

Investments in debt securities are classified on the acquisition dates and at each balance sheet date. Securities classified as held-to-maturity are carried at amortized cost, net of allowance for credit losses, reflecting the ability and intent to hold the securities to maturity. Debt securities classified as trading are acquired with the intent to sell in the near term and are carried at fair value with changes reported in earnings. All other debt securities are classified as available-for-sale and are carried at fair value.

Investment gains and losses on available-for-sale debt securities are recorded when the securities are sold, as determined on a specific identification basis, and recognized in current period earnings. Changes in unrealized gains on available-for-sale debt securities are reported net of tax in accumulated other comprehensive income (loss). For debt securities in an unrealized loss position, a loss in earnings is recognized for the excess of amortized cost over fair value if the Company intends to sell before the price recovers. Otherwise, the Company evaluates as of the balance sheet date whether the unrealized losses are attributable to credit losses or other factors. The severity of the decline in value, creditworthiness of the issuer and other relevant factors are considered. The portion of unrealized loss the Company believes is related to a credit loss is recognized in earnings, and the portion of unrealized loss the Company believes isnot related to a credit loss is recognized in other comprehensive income (loss).

Certain derivatives embedded in other financial instruments, such as the conversion option in a convertible bond, are reported at fair value, and changes in fair value are recorded through earnings within net investment income (loss). The host contract continues to be accounted for in accordance with the appropriate accounting standard. The embedded derivative and the related host contract representone legal contract and are combined on the Consolidated Balance Sheets and the table that follows.

The Company heldone financial instrument classified as available-for-sale containing an embedded derivative, representing an investment in HIVE, at* June 30, 2025*. At that date, the fair value of the embedded derivative was zero. During the prior fiscal years, the Company recognized unrealized losses related to this embedded derivative through earnings. In* December 2025,the remaining principal amount of the Company’s investment in available-for-sale debt securities containing a conversion option was paid in full, resulting in the realization of a loss of $2.5 million on the expired embedded derivative. As this loss had been previously recognized as unrealized in prior years, the realization hadno* net impact on net investment income (loss) for the current fiscal year.

Page11

The following details the components of the Company’s available-for-sale debt investments as of* June 30, 2025*. There wereno available-for-sale debt investments as of* March 31, 2026*.

The following table presents the effect of embedded derivatives on the Consolidated Statements of Operations, categorized by risk exposure, for thethree andnine months ended* March 31, 2026,and2025*.

At* March 31, 2026*, and* June 30, 2025*, the Company heldone debt security classified as held-to-maturity. The following details are the components of the Company’s held-to-maturity debt investments as of* March 31, 2026*, and* June 30, 2025*.

Page12

The Company applies the Current Expected Credit Losses (“CECL”) model to held-to-maturity debt securities. The allowance, which requires significant judgment, reflects lifetime expected credit losses and is deducted from amortized cost to present the net amount expected to be collected. Securities, or portions thereof, are charged against the allowance when deemed uncollectible, and the balance* may*change as economic conditions or issuer prospects evolve.

The Company monitors the credit quality of debt securities through credit ratings from various rating agencies. Credit ratings express opinions about the credit quality of a security and are utilized by the Company to make informed decisions. Investment grade securities are rated BBB-/Baa3 or higher and generally considered by the rating agencies and market participants to be of low credit risk. Conversely, securities rated below investment grade are considered to have distinctively higher credit risk than investment grade securities. For securities without credit ratings, the Company utilizes other financial information indicating the financial health of the underlying organization. As of* March 31, 2026*, and* June 30, 2025*, the held-to-maturity debt investment held by the Company didnot have a credit rating.

Since the held-to-maturity debt security doesnot have a credit rating, management has determined that the discounted cash flow method provides the best basis for its assessment and determination of expected credit losses. The Company has elected to reflect the change in the allowance solely attributable to the passage of time in interest income. Changes attributable to the passage of time are those solely due to changes in the present value of the expected cash flows as the instrument approaches maturity rather than expectations of cash flow timing or amounts. The change in allowance for credit losses attributable to the passage of time, included as an increase in interest income within net investment income (loss) on the Consolidated Statements of Operations, was $2,000 and $13,000 for thethree andnine months ended* March 31, 2026*, respectively, and $3,000 and $61,000 for thethree andnine months ended* March 31, 2025*, respectively.

The following table presents the activity in the allowance for credit losses for the held-to-maturity debt investment for thenine months ended* March 31, 2026*, and2025.

The following summarizes the net carrying amount and estimated fair value of held-to-maturity debt securities at* March 31, 2026*, by contractual maturity dates.

As of* March 31, 2026*, and* June 30, 2025*,none of the Company’s investments in debt securities classified as held-to-maturity or available-for-sale were delinquent or in a non-accrual status. Accrued interest receivable of $25,000 and $40,000 is included in accounts and other receivables on the Consolidated Balance Sheets as of* March 31, 2026*, and* June 30, 2025*, respectively. The accrued interest receivable as of* June 30, 2025*, includes amounts related to the Company's available-for-sale debt security, which wasnot held as of* March 31, 2026*.

Other Investments

Other investments consist of equity investments in entities over which the Company doesnot exercise significant influence and that donot have readily determinable fair values. These investments are accounted for under the measurement alternative in accordance with ASC321, whereby securities are measured at cost, less impairment, if any, and adjusted for observable price changes in orderly transactions for identical or similar securities of the same issuer. When observable price changes are identified, the carrying value of the related equity security is adjusted to reflect the observable transaction price as of the transaction date, with the resulting gains or losses recognized in net investment income (loss). The Company doesnot perform recurring fair value remeasurements of these equity securities absent such observable transactions or indicators of impairment.

The carrying value of equity securities without readily determinable fair values was approximately $1.3 million as of* June 30, 2025*. The following table presents the carrying value of equity securities without readily determinable fair values held as of* March 31, 2026,and2025*, that are measured under the measurement alternative, as well as the related adjustments recorded during the periods presented for those securities with observable price changes or impairments. These securities are included in the nonrecurring fair value hierarchy tables when observable price changes occur or when impairments are recognized.

The period-end carrying values reflect cumulative purchases and sales, as well as upward and downward carrying adjustments resulting from observable price changes and impairment assessments. Through* March 31, 2026*, the cumulative amount of upward adjustments to all equity securities without readily determinable fair values totaled $5.8 million since their respective acquisition dates. These upward adjustments were recorded solely in connection with observable price changes in orderly transactions andnot as a result of recurring fair value measurements. The most recent upward adjustment was based on an observable transaction involving an issuance of similar equity securities by the issuer during the period. The Company considered the transaction price in that issuance and concluded that it represented an observable price change under ASC321. Accordingly, the carrying value of the investment was adjusted under the measurement alternative.

Page13

The cumulative amount of impairments and other downward adjustments to all equity securities without readily determinable fair values totaled $5.4 million through* March 31, 2026*. Downward adjustments include impairments identified based on qualitative assessments, return-of-capital distributions, and decreases in carrying value resulting from observable price changes.

Net Investment Income (Loss)

Net investment income (loss) from the Company’s investments includes:

The following summarizes net investment income (loss) reflected in earnings for the periods presented.

Realized gains on debt securities reclassified from other comprehensive income (loss) related to the Company's investment in HIVE debentures were $108,000 for thenine months ended* March 31, 2026*, withno reclassifications in thethree-month period, compared with $134,000 and $507,000 for thethree andnine months ended* March 31, 2025*, respectively.

The following table presents net unrealized gains (losses) recognized in net investment income (loss) during thethree andnine months ended* March 31, 2026,and2025*, related to equity securities and debt securities classified as trading that were held as of the respective period-end dates.

Net investment income (loss) can be volatile and vary depending on market fluctuations, the Company’s ability to participate in investment opportunities, and the timing of transactions. The Company expects that gains and losses will continue to fluctuate in the future.

Page14

NOTE3. INVESTMENT MANAGEMENT AND OTHER FEES

The following table presents operating revenues disaggregated by performance obligation.

The Company serves as investment advisor tofour U.S.-based ETF clients: U.S. Global Jets ETF (ticker JETS), U.S. Global GO GOLD and Precious Metal Miners ETF (ticker GOAU), U.S. Global Sea to Sky Cargo ETF (ticker SEA), and the U.S. Global Technology and Aerospace & Defense ETF (ticker WAR). The Company receives a unitary management fee of 0.60 percent of average net assets and has agreed to bear all expenses of the U.S.-based ETFs, except the U.S. Global Sea to Sky Cargo ETF ("SEA"). The Company has agreed to contractually limit the expenses of SEA through* April 2027*. For thethree andnine months ended* March 31, 2026*, aggregate fees waived and expenses borne by the Company for SEA were $33,000 and $105,000, respectively, including waived fees of $20,000 and $47,000, respectively. For thethree andnine months ended* March 31, 2025*, aggregate fees waived and expenses borne by the Company for SEA were $33,000 and $111,000, respectively, including waived fees of $9,000 and $28,000, respectively. The Company also serves as an investment advisor toone European-based ETF, The Travel UCITS ETF (ticker TRIP). The Company receives a unitary management fee of 0.69 percent of average net assets and has agreed to bear all expenses of the European-based ETF.

The Company serves as investment adviser to USGIF and earns a base management fee calculated as a specified percentage of average net assets under management. During fiscal year2025, the Company also received performance fees, which were fulcrum fees consisting of a 0.25 percent upwards or downwards adjustment of the base management fee when there was a 5 percent or more performance difference between a fund’s performance and that of its designated benchmark index over the prior rolling12 months. This performance adjustment began to be phased out during thefourth quarter of fiscal2024 and ceased during thefourth quarter of fiscal2025. During the phase-out period, the adjustment for the performance fee could only be adjusted downward.

The Company has agreed to contractually limit the expenses of the Funds except the U.S. Government Securities Ultra-Short Bond Fund through* April 2027*. The Company has voluntarily waived or reduced its fees and/or agreed to pay expenses on the U.S. Government Securities Ultra-Short Bond Fund. This cap will continue on a voluntary basis at the Company’s discretion. For thethree andnine months ended* March 31, 2026*, aggregate fees waived and expenses borne by the Company for USGIF were $172,000 and $588,000, respectively, including waived fees of $125,000 and $417,000, respectively. For thethree andnine months ended* March 31, 2025*, aggregate fees waived and expenses borne by the Company for USGIF were $211,000 and $743,000, respectively, including waived fees of $167,000 and $587,000, respectively. USGIF revenue included on the Consolidated Statements of Operations is net of fee waivers. Management cannot predict the impact of future waivers due to the number of variables and the range of potential outcomes.

The Company receives administrative service fees from USGIF based on an annual rate of 0.05 percent on the average daily net assets of each fund.

As of* March 31, 2026*, the Company had $872,000 in receivables from fund clients, of which $483,000 was from the ETFs and $389,000 was from USGIF. As of* June 30, 2025*, the Company had $683,000 in receivables from fund clients, of which $494,000 was from the ETFs and $189,000 was from USGIF. There wasno allowance for credit losses related to receivables as of* March 31, 2026*, or* June 30, 2025*.

Page15

NOTE4. RESTRICTED AND UNRESTRICTED CASH

The Company maintains its cash deposits with established commercial banks. At times, balances* mayexceed federally insured limits. We havenot* experienced any losses in such accounts and donot believe that we are exposed to any significant credit risk associated with our cash deposits. Restricted cash represents cash invested in a money market account as collateral for credit facilities that isnot available for general corporate use.

A reconciliation of cash, cash equivalents, and restricted cash reported from the Consolidated Balance Sheets to the Consolidated Statements of Cash Flows is shown below.

NOTE5. LEASES

The Company has lease agreements for office equipment that expire in fiscal year2029. Lease expenses included in general and administrative expense on the Consolidated Statements of Operations totaled $24,000 and $80,000 for thethree andnine months ended* March 31, 2026*, respectively, and $25,000 and $75,000 for thethree andnine months ended* March 31, 2025*, respectively.

The following table presents the components of lease cost.

Supplemental information related to the Company's leases follows.

Additional qualitative information concerning the Company’s leases follows.

The following table presents the maturities of lease liabilities as of* March 31, 2026*.

The Company is the lessor of certain areas of its owned office building under operating leases expiring in various months through fiscal year2028. At the commencement of an operating lease,no income is recognized; subsequently, lease payments received are recognized on a straight-line basis. Lease income included inother income on the Consolidated Statements of Operations was $30,000 and $88,000 for thethree andnine months ended* March 31, 2026*, respectively, and $28,000 and $75,000 for thethree andnine months ended* March 31, 2025*, respectively. The Company is party to a lease agreement with HIVE, a related party, for certain areas of the Company’s office building. The terms of the lease were determined to be consistent with market rates.

Page16

The following is a summary analysis of annual undiscounted cash flows to be received on leases as of* March 31, 2026*.

The Company* mayterminate the building leases withone hundred eighty* days written notice if it sells the property. If the Company terminates the lease, the Company will pay the tenant a termination fee of the lesser ofsix months of the base monthly rent or the base monthly rent times the number of months remaining in the initial term.

NOTE6. OTHER ACCRUED EXPENSES

Other accrued expenses consist of the following:

A portion of other accrued expenses relates to out-of-pocket expenses incurred by the Company are reimbursable by HIVE. Receivables from HIVE for these reimbursable out-of-pocket expenses amounted to $134,000 and $239,000 as of* March 31, 2026*, and* June 30, 2025*, respectively, are included within accounts and other receivables on the Consolidated Balance Sheets.

NOTE7. DEBT

The Company has access to a $1.0 million credit facility for working capital purposes. The credit agreement requires the Company to maintain certain covenants; the Company has been in compliance with these covenants during the current fiscal year. The credit agreement expires on* May 31,2026, and the Company intends to renew it biennially. The credit facility is collateralized by approximately $1.0 million at March 31, 2026*, included in restricted cash on the Consolidated Balance Sheets, held in deposit in a money market account at the financial institution that provided the credit facility. As of* March 31, 2026*, the credit facility remains unutilized by the Company.

During fiscal2025, the Company received loan proceeds of $75,000 from an entity in which it holds an equity investment. The loan is non-interest bearing, non-recourse, and will be repaid through an offset against amounts due upon the entity's final liquidation. Because the timing of liquidation is uncertain, the loan is classified as non-current within notes payable on the Consolidated Balance Sheets.

NOTE8. STOCKHOLDERS’** EQUITY**

Payment of cash dividends is within the discretion of the Company’s Board of Directors and is dependent on earnings, operations, capital requirements, general financial condition of the Company, and general business conditions. The dividend rate per share was $0.0075 per month for fiscal year2025 and through* March 2026*.

In* March 2026*, the Board authorized the continuance of the monthly dividend of $0.0075 per share from* April* through* June 2026*, at which time it will be considered for continuation by the Board.

The Company has a share repurchase program, approved by the Board of Directors, authorizing the Company to annually purchase up to $5.0 million of its outstanding common shares, as market and business conditions warrant, on the open market in compliance with Rule10b-18 and Rule10b5-1 of the Securities Exchange Act of1934. The repurchase program has been in place since* December 2012,and the Board of Directors has annually renewed the repurchase program each calendar year. The Company announced on February 25, 2022,that the Board of Directors of the Company approved an increase to the limit of its annual share buyback program from $2.75 million to $5.0 million. The Company announced on September 19, 2024,that the Board of Directors of the Company approved an update authorizing the Company to repurchase up to $5.0 million of its outstanding common shares between September 13, 2024,and December 31, 2024.As a result, the total amount of shares that maybe repurchased under the program was $6.5 million in2024* and $5.0 million in each of2025 and2026. The acquired shares* maybe used for corporate purposes, including shares issued to employees in the Company’s stock-based compensation programs. During thethree* andnine months ended* March 31, 2026*, the Company repurchased 176,592 and 597,861 class A shares for $534,000 and $1.6 million, respectively. During thethree andnine months ended* March 31, 2025*, the Company repurchased 187,987 and 622,605 class A shares for $454,000, and $1.6 million, respectively.

The Inflation Reduction Act of2022 imposes a1% excise tax on stock buybacks by publicly traded corporations. Any excise tax incurred is recognized as part of the cost basis of the shares acquired in the Consolidated Statements of Shareholders' Equity. The impact of these provisions was $5,000 and $15,000 for thethree andnine months ended* March 31, 2026*, respectively, and $5,000 and $15,000 for thethree andnine months ended* March 31, 2025*, respectively. All amounts presented in this report related to the Company's share repurchases and the Company's share repurchase authorization exclude such excise taxes, to the extent applicable, unless otherwise indicated.

Page17

Stock Option Plans

The Company’s stock option plans allow for the granting of class A shares as either incentive or non-qualified stock options to employees and non-employee directors. The terms and conditions of these options, including exercise price, vesting schedule, and expiration, are determined by the Compensation Committee of the Board of Directors.

Under the1989 Plan, there were 352,000 and 228,000 stock options outstanding and exercisable as of* March 31, 2026*, and2025, respectively. The weighted average exercise prices of these options were $4.76 and $6.05, respectively. There wereno nonvested stock options outstanding as of* March 31, 2026*, and 125,100 nonvested stock options outstanding as of* March 31, 2025*, with a weighted average exercise of $2.41.

Under the1997 Plan, there were 2,000 stock options outstanding and exercisable as of both* March 31, 2026,and March 31, 2025*, with a weighted average exercise price of $2.74.

Stock Option Activity

During thethree andnine months ended* March 31, 2026*, no stock options were granted or exercised, and 200 options were forfeited. During thethree andnine months ended* March 31, 2025*, the Company granted 25,000 and 125,100 stock options, respectively, with weighted‑average grant‑date fair values of $0.99 and $1.06 and a six‑month vesting period. No stock options were exercised in either period in fiscal2025, and forfeitures of 1,000 options occurred only during thenine-month period in fiscal2025.

Share-Based Compensation Expense

The Company measures share-based compensation expense at the grant date, based on the fair value of the awards. This expense is recognized ratably over the awards’ vesting period. No share-based compensation expense was recognized for thethree months ended* March 31, 2026*. Share-based compensation expense of $9,000 was recognized for thenine months ended* March 31, 2026*, and $58,000 and $68,000 was recognized for thethree andnine months ended* March 31, 2025*, respectively. As of* March 31, 2026*, there wereno unrecognized share-based compensation costs related to share-based awards under the plans. As of* March 31, 2025*, unrecognized share-based compensation costs totaled $65,000.

NOTE9. EARNINGS PER SHARE

The basic earnings per share (“EPS”) calculation excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution of EPS that could occur if options to issue common stock were exercised.

The following table sets forth the computation for basic and diluted EPS.

The diluted EPS calculation excludes the effect of stock options when their exercise prices exceed the average market price for the period, as their inclusion would be anti-dilutive. For thethree andnine months ended* March 31, 2026*, employee stock options of 227,000 and 229,000, respectively, were excluded from diluted EPS. For thethree andnine months ended* March 31, 2025*, employee stock options of 330,100 and 230,000, respectively, were excluded from diluted EPS.

During thethree andnine months ended* March 31, 2026*, and2025, the Company repurchased class A shares on the open market. Upon repurchase, these shares are classified as treasury shares and are deducted from outstanding shares in the earnings per share calculation.

Page18

NOTE10. INCOME TAXES

The Company and its non-Canadian subsidiaries file a consolidated U.S. federal income tax return. USCAN files a separate tax return in Canada. Provisions for income taxes include deferred taxes for temporary differences between the financial reporting and tax basis of assets and liabilities, resulting from the use of the liability method of accounting for income taxes.

Income tax expense for the quarter is based upon the estimated annual ordinary income in each jurisdiction in which the Company operates. The tax effects of discrete items are recognized in the tax provision in the period they occur in accordance with U.S. GAAP. Due to various factors, such as the item’s significance in relation to total ordinary income and the rate of tax, discrete items in any quarter can materially impact the reported effective tax rate ("ETR"). A valuation allowance is provided when it is more likely thannot that some portion of the deferred tax amount willnot be realized. There wasno valuation allowance recorded at* June 30, 2025*.

As of* March 31, 2026*, the Company recorded a valuation allowance of $26,000 against deferred tax assets, primarily capital loss carryforwards. The realization of capital loss carryforwards is dependent upon future capital gains. The Company concluded that it was more-likely-than-not that a portion of these deferred tax assets wouldnot be realized.

In addition, income tax expense for thethree months ending* March 31, 2026,was reduced by discrete items, primarily a481*(a) adjustment related to the federal income tax treatment of certain HIVE securities and a decrease in the valuation allowance. As a result, the Company's effective tax rate* may**not* be comparable between periods. The effective tax rate was (46.0) and 20.8 percent for thethree andnine months ended* March 31, 2026*, respectively, and (55.9) and 301.3 percent for thethree andnine months ended* March 31, 2025*, respectively.

The Company maintains a reserve for uncertain tax positions for income tax matters. As of* March 31, 2026*, and* June 30, 2025*, the total reserve for uncertain tax positions, including $387,000 and $421,000 of accrued interest and penalties, respectively, and net of federal benefits, was $845,000 and $891,000, respectively. These amounts are included within long-term liabilities on the Consolidated Balance Sheets. The Company believes the reserve balance as of* March 31, 2026*, including interest and penalties and net of federal benefits, adequately covers open tax years and uncertain tax positions for major taxing jurisdictions. If recognized, the entire $845,000 of unrecognized tax benefits would impact the Company's effective income tax rate.

On* July 4, 2025,President Trump signed into law Public Law119*-21, commonly known as the One Big Beautiful Bill Act (the “Act”), which contained several tax reform proposals. A Company is required to adjust current and deferred tax liabilities and assets for the effects of changes in tax laws or rates in income from continuing operations in the interim period that includes the enactment date. The impact of the Act is reflected in the Company’s interim results for thethree andnine months ended* March 31, 2026*, and is immaterial.

NOTE11. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The following table presents the change in accumulated other comprehensive income (loss) (“AOCI”) by component.

Page19

NOTE12. FINANCIAL INFORMATION BY BUSINESS SEGMENT

The Company manages the following business segments:

These segments are managed separately. The Company’s segment information is prepared on the same basis that management uses to review the financial information for operational and investment decision-making purposes. All segment accounting policies are the same as those described in the summary of significant accounting policies.

The Company's Chief Executive Officer, serving as the Chief Operating Decision Maker ("CODM"), evaluates the performance of the Company’s Corporate Investments segment separately from the Investment Management Services segment based on net investment income (loss), and the Corporate Investments segment doesnot include any allocated company expenses. All significant expenses are disclosed on the Consolidated Statements of Operations. The CODM evaluates the performance of the Company’s Investment Management Services segment based on operating income (loss) before depreciation, interest, and income taxes.

The following schedule details total revenues, income, and gross identifiable assets by business segment:

Page20

Operating revenues from investment management services include revenues from ETF clients of $1.5 million and $4.6 million for thethree andnine months ended* March 31, 2026*, respectively, and $1.7 million and $5.3 million for thethree andnine months ended* March 31, 2025*, respectively. Operating revenues from investment management services also include revenues from USGIF of $1.2 million and $2.9 million for thethree andnine months ended* March 31, 2026*, respectively, and $446,000 and $1.2 million for thethree andnine months ended* March 31, 2025*, respectively.

NOTE13. CONTINGENCIES AND COMMITMENTS

The Company continuously reviews investor, employee and vendor complaints, and pending or threatened litigation. The likelihood that a loss contingency exists is evaluated through consultation with legal counsel, and a loss contingency is recorded if probable and reasonably estimable.

During the normal course of business, the Company* maybe subject to various claims, legal proceedings, and other contingencies. These matters are subject to various uncertainties, and it is possible that some of these matters maybe resolved unfavorably. The Company establishes accruals for matters for which the outcome is probable and can be reasonably estimated. Management believes that any liability in excess of these accruals upon the ultimate resolution of these matters willnot* have a material adverse effect on the Consolidated Financial Statements of the Company. Excluding reserves for uncertain tax positions, the Company recordedno accruals for contingencies as of* March 31, 2026*, or* June 30, 2025*.

The Board has authorized a monthly dividend of $0.0075 per share through* June 2026*, at which time it will be considered for continuation by the Board. Payment of cash dividends is within the discretion of the Company’s Board of Directors and is dependent on earnings, operations, capital requirements, general financial condition of the Company, and general business conditions. The total amount of cash dividends expected to be paid to class A and class C shareholders from* April* to* June 2026* is approximately $282,000.

Note14. Subsequent EventS

The Company evaluated subsequent events through the filing date of this Quarterly Report on Form10-Q and determined that there wereno subsequent events requiring recognition or disclosure in the accompanying Consolidated Financial Statements.

Page21